Growth Metrics

Cellectis (CLLS) Current Deferred Revenue: 2014-2022

Historic Current Deferred Revenue for Cellectis (CLLS) over the last 5 years, with Dec 2022 value amounting to $59,000.

  • Cellectis' Current Deferred Revenue fell 53.91% to $59,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $59,000, marking a year-over-year decrease of 53.91%. This contributed to the annual value of $59,000 for FY2022, which is N/A change from last year.
  • As of FY2022, Cellectis' Current Deferred Revenue stood at $59,000, which was down 99.77% from $26.1 million recorded in FY2017.
  • In the past 5 years, Cellectis' Current Deferred Revenue ranged from a high of $59,000 in FY2022 and a low of $59,000 during FY2022.
  • Over the past 1 years, Cellectis' median Current Deferred Revenue value was $59,000 (recorded in 2022), while the average stood at $59,000.